{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:26:02Z","timestamp":1780932362186,"version":"3.54.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jns.2017.10.022","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T03:31:00Z","timestamp":1508124660000},"page":"39-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment"],"prefix":"10.1016","volume":"383","author":[{"given":"Andrea","family":"Mignarri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam","family":"Carecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Del Puppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Magistrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Di Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Dotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.10.022_bb0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ajhg.2007.10.001","article-title":"Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration","volume":"82","author":"Tsaousidou","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2017.10.022_bb0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/brain\/awp073","article-title":"CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5","volume":"132","author":"Goizet","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.10.022_bb0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1194\/jlr.M002543","article-title":"Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis","volume":"51","author":"Sch\u00fcle","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jns.2017.10.022_bb0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","article-title":"Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain","volume":"46","author":"Heverin","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jns.2017.10.022_bb0025","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s00415-015-7971-5","article-title":"Treatment of SPG5 with cholesterol-lowering drugs","volume":"262","author":"Mignarri","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.10.022_bb0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","article-title":"The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity","volume":"67","author":"Sch\u00fcle","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.10.022_bb0035","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s00415-009-5109-3","article-title":"Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study","volume":"256","author":"Criscuolo","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.10.022_bb0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00415-014-7253-7","article-title":"Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism","volume":"261","author":"Mignarri","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.10.022_bb0045","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1172\/JCI2962","article-title":"Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease","volume":"102","author":"Setchell","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2017.10.022_bb0050","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00415-014-7247-5","article-title":"Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1","volume":"261","author":"Di Fabio","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.10.022_bb0055","doi-asserted-by":"crossref","first-page":"48158","DOI":"10.1074\/jbc.M205244200","article-title":"Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes","volume":"277","author":"Pandak","year":"2002","journal-title":"J. Biol. Chem."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17343873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17343873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T06:51:41Z","timestamp":1530600701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17343873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":11,"alternative-id":["S0022510X17343873"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.10.022","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}